Cargando…
Concerns regarding use of Patient Reported Outcomes in Biomarker Studies of Chemotherapy-Induced Peripheral Neuropathy
Clinician-rated toxicity data has been systematically collected within oncology clinical research using the National Cancer Institute’s CTCAE scale, providing estimates of the occurrence and severity of toxicity from cancer treatment. CTCAE is being supplemented by collection of patient-reported out...
Autor principal: | Hertz, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754778/ https://www.ncbi.nlm.nih.gov/pubmed/31395959 http://dx.doi.org/10.1038/s41397-019-0093-1 |
Ejemplares similares
-
Chemotherapy-induced peripheral neuropathy
por: Zhang, Xia, et al.
Publicado: (2017) -
Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions
por: Rodwin, Rozalyn L., et al.
Publicado: (2022) -
Addressing Chemotherapy-Induced Peripheral Neuropathy Using Multi-Frequency Vibrometry and Patient-Reported Outcomes
por: Nielsen, Sebastian W., et al.
Publicado: (2022) -
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
por: Zajączkowska, Renata, et al.
Publicado: (2019) -
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
por: Starobova, Hana, et al.
Publicado: (2017)